我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。

开放获取期刊获得更多读者和引用
700 种期刊 15,000,000 名读者 每份期刊 获得 25,000 多名读者

索引于
  • 哥白尼索引
  • 谷歌学术
  • 打开 J 门
  • Genamics 期刊搜索
  • 宇宙IF
  • 参考搜索
  • 哈姆达大学
  • 亚利桑那州EBSCO
  • OCLC-世界猫
  • 普布隆斯
  • 日内瓦医学教育与研究基金会
  • 欧洲酒吧
  • ICMJE
分享此页面

抽象的

Opioid-Induced Gastrointestinal Dysfunction (OGD): A Questionnaire Survey of Chronic Opioid Users

Spierings ELH*

In order to gain insight into the symptoms of opioid-induced gastrointestinal dysfunction, we conducted a questionnaire survey among 119 daily prescription-opioid users, also to understand how they deal with the dysfunction, with or without physician assistance, using the abundantly available, over-the-counter constipation remedies. Almost 80% had constipation, as opposed to almost 20% before taking opioids, and more than 60% had constipation despite the use of constipation remedies. More than half had bowel movements 1 to 3 times per week, which was the case in slightly over 20% before taking opioids. Despite the use of constipation remedies, straining, incomplete evacuation, rectal impaction, and hard stool were common. Of these symptoms, hard stool was considered to be the most bothersome, followed by flatulence, abdominal discomfort/pain, false alarm, and abdominal bloating. Relatively serious complications of the constipation, such as hemorrhoids, anal fissures, rectal impaction, and rectal prolapse, were reported by 20% to 40% of patients. Of the stomach symptoms per se, anorexia and acid reflux were relatively common, warranting the term opioid-induced gastrointestinal dysfunction.